Emily Chen is a health economist and director of Global Access Strategy & Pricing at Pfizer, specializing in COVID-19 treatments. They have previously served as an Associate Consultant at Simon-Kucher & Partners, focusing on market access and pricing strategies. At Pfizer, they have undertaken several roles, including Commercial Development Lead for antivirals, Access Strategy Lead for anti-infectives and antivirals, and Advisor to the Senior Manager in Health Economics & Outcomes Research. Emily is currently pursuing multiple master's degrees in Medical and Pharmaceutical Drug Innovation and International Healthcare Management, while also studying violin at the Sichuan Conservatory of Music.
This person is not in any teams
This person is not in any offices